Search research articles
Contact Us
Filters
Showing results (1-10 of 203) with videos related to
Page
of 21
Sort By:
BMC Neurology
|
October 30, 2010
The genetic basis of multiple sclerosis: a model for MS susceptibility
Douglas S Goodin
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 21, 1999
Survey of multiple sclerosis in northern California. Northern California MS Study Group
D S Goodin
Psychosomatic Medicine
|
March 25, 2004
Relationship between multiple sclerosis exacerbations and stress
Douglas S Goodin
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 5, 1998
A questionnaire to assess neurological impairment in multiple sclerosis
D S Goodin
Annals of Neurology
|
March 28, 2006
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Douglas S Goodin
Electroencephalography and Clinical Neurophysiology
|
July 1, 1990
Clinical utility of long latency 'cognitive' event-related potentials (P3): the pros
D S Goodin
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 3, 2024
Pathogenesis of multiple sclerosis: genetic, environmental and random mechanisms
Douglas S Goodin
Biological Psychiatry
|
October 1, 1986
P300 latency as a biologic marker of dementia
D S Goodin
Journal of Neurology
|
November 19, 2004
Disease-modifying therapy in MS: a critical review of the literature. Part II: Assessing efficacy and dose-response
Douglas S Goodin
Journal of Neurology
|
July 18, 2006
Interferon beta in relapsing-remitting multiple sclerosis: an eight years experience in a specialist multiple sclerosis centre
D S Goodin
Page
of 21
Search research articles
Search
Showing results (1-10 of 203) with videos related to
Sort By:
Page
of 21
BMC Neurology
|
October 30, 2010
The genetic basis of multiple sclerosis: a model for MS susceptibility
Douglas S Goodin
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
May 21, 1999
Survey of multiple sclerosis in northern California. Northern California MS Study Group
D S Goodin
Psychosomatic Medicine
|
March 25, 2004
Relationship between multiple sclerosis exacerbations and stress
Douglas S Goodin
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 5, 1998
A questionnaire to assess neurological impairment in multiple sclerosis
D S Goodin
Annals of Neurology
|
March 28, 2006
Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Douglas S Goodin
Electroencephalography and Clinical Neurophysiology
|
July 1, 1990
Clinical utility of long latency 'cognitive' event-related potentials (P3): the pros
D S Goodin
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 3, 2024
Pathogenesis of multiple sclerosis: genetic, environmental and random mechanisms
Douglas S Goodin
Biological Psychiatry
|
October 1, 1986
P300 latency as a biologic marker of dementia
D S Goodin
Journal of Neurology
|
November 19, 2004
Disease-modifying therapy in MS: a critical review of the literature. Part II: Assessing efficacy and dose-response
Douglas S Goodin
Journal of Neurology
|
July 18, 2006
Interferon beta in relapsing-remitting multiple sclerosis: an eight years experience in a specialist multiple sclerosis centre
D S Goodin
Page
of 21